Drug Regulatory Science:Collaborate to improve drug development and evaluation

In my lecture I will focus on important developments in European drug regulation, such as personalized medicines, real world data, patient centricity and knowledge exchange. The lecture will acknowledge the long standing collaboration between the Dutch Medicines Evaluation Board and the department of Clinical Pharmacy and Pharmacology. It will also emphasize the need for collaboration between European regulators and other stakeholders to improve drug development and regulation